리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 308 Pages
라이선스 & 가격 (부가세 별도)
한글목차
단백질 어세이 세계 시장은 2030년까지 37억 달러에 도달
2023년에 24억 달러로 추정되는 단백질 어세이 세계 시장은 분석 기간인 2023-2030년에 CAGR 6.3%로 성장하여 2030년에는 37억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 단백질 어세이 키트는 CAGR 5.6%를 나타내고, 분석 기간 종료시에는 9억 3,840만 달러에 이를 것으로 예측됩니다. 단백질 어세이 기기 및 액세서리 분야의 성장률은 분석 기간중 CAGR 6.2%로 추정됩니다.
미국 시장은 6억 3,720만 달러, 중국은 CAGR 5.9%로 성장 예측
미국 단백질 어세이 시장은 2023년에 6억 3,720만 달러로 추정됩니다. 세계 2위 경제대국인 중국은2023-2030년 CAGR을 5.9%로서 2030년까지 5억 7,550만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 5.7%와 5.2%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.8%로 성장할 것으로 예측됩니다.
세계 단백질 어세이 시장 - 주요 동향 및 촉진요인 요약
확대되는 단백질 어세이 시장의 가능성 분석
단백질 어세이는 생명과학 연구의 기본 도구로, 다양한 생물학적 시료에서 단백질을 정량하고 분석할 수 있습니다. 이러한 분석은 단백질의 기능, 구조 및 상호 작용을 이해하는 데 필수적이며 신약, 진단 및 치료법 개발에 필수적입니다. 단백질에 대한 대규모 연구인 단백질체학에 대한 관심이 높아지면서 단백질 어세이에 대한 수요가 크게 증가하고 있습니다. 생명공학, 제약, 임상 진단 등의 분야에서 단백질 어세이는 품질 관리, 신약 개발 및 질병 진단에 필수적입니다. 만성 질환 증가와 개인 맞춤형 의료의 필요성은 현대 의료에서 정확하고 신뢰할 수 있는 단백질 어세이의 중요성을 더욱 강조하고 있습니다.
기술의 발전은 시장에 어떤 영향을 미치고 있는가?
기술의 발전은 단백질 어세이의 발전에 있어 매우 중요한 역할을 하고 있습니다. 고처리량 분석 및 자동화 시스템의 개발은 이 분야에 혁명을 일으켜 복잡한 생물학적 시료에서 단백질을 빠르고 정확하게 정량할 수 있게 했습니다. 형광 및 발광 기반 분석의 혁신은 감도와 특이성을 향상시켜 연구자들이 저 존재 단백질을 보다 정확하게 검출할 수 있게 했습니다. 마이크로fluidics와 랩온칩 기술의 통합은 또한 효율성과 확장성을 향상시켜 다양한 분야의 연구자들이 쉽게 사용할 수 있도록 했습니다. 또한, 생물정보학 및 데이터 분석 도구의 발전은 복잡한 단백질 데이터의 해석을 용이하게 하고, 연구 및 임상 현장에서 고급 단백질 어세이의 채택을 더욱 촉진하고 있습니다.
단백질 어세이의 새로운 응용 분야는 무엇인가?
단백질 어세이는 맞춤의료, 바이오마커 탐색, 면역치료 등 새로운 분야에서 점점 더 많이 적용되고 있습니다. 개인 맞춤형 의료에서 단백질 어세이는 개별 환자의 표적 치료법을 선택하는 데 도움이 되는 특정 바이오마커를 식별하는 데 사용됩니다. 또한, 특히 암 치료에서 면역 요법의 부상으로 인해 면역 체크포인트 단백질의 발현 수준을 평가할 수 있는 단백질 어세이에 대한 수요가 증가하고 있으며, 이는 이러한 치료법의 효과를 판단하는 데 중요한 역할을 하고 있습니다. 또한, 단백질 어세이는 환자 침대 옆에서 신속하고 정확한 결과를 제공하는 현장 검사 등 새로운 진단 도구의 개발에도 사용되고 있습니다. 이러한 새로운 응용 분야의 출현으로 단백질 어세이의 연구 및 임상 범위와 유용성이 확대되고 있습니다.
시장 성장의 주요 촉진요인은 무엇인가?
단백질 어세이 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 단백질체학에 대한 관심이 높아지고 단백질의 기능과 상호 작용을 연구하기 위한 첨단 도구의 필요성이 주요 촉진요인입니다. 높은 처리량과 자동화된 분석법 개발과 같은 기술 발전은 단백질 정량의 효율성과 정확성을 크게 향상시켜 연구 및 임상 현장에서의 채택을 촉진하고 있습니다. 만성질환의 확산과 개인 맞춤형 의료에 대한 수요도 신뢰할 수 있는 단백질 어세이의 필요성을 더욱 촉진하고 있습니다. 특히 바이오마커 발굴과 면역치료 분야의 새로운 응용 분야가 시장을 더욱 확대시키고 있습니다. 또한, 첨단 데이터 분석 도구와 바이오인포매틱스의 통합은 단백질 어세이의 유용성을 높여 현대 생명과학 연구에 필수적인 요소로 자리 잡고 있습니다.
조사 대상 기업 예(주목 11사)
Abcam PLC
Bio-Rad Laboratories, Inc.
Biovision Inc.
Cell Signaling Technology, Inc.
GE Healthcare Life Sciences
Geno Technology Inc.
Lonza Group AG
Merck KgaA
Novus Biologicals LLC
PerkinElmer, Inc.
Promega Corporation
Thermo Fisher Scientific, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
LSH
영문 목차
영문목차
Global Protein Assays Market to Reach US$3.7 Billion by 2030
The global market for Protein Assays estimated at US$2.4 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Protein Assays Kits, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$938.4 Million by the end of the analysis period. Growth in the Protein Assays Instruments & Accessories segment is estimated at 6.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$637.2 Million While China is Forecast to Grow at 5.9% CAGR
The Protein Assays market in the U.S. is estimated at US$637.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$575.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Global Protein Assays Market - Key Trends and Drivers Summarized
Analyzing the Potential: The Expanding Market for Protein Assays
Protein assays are fundamental tools in life sciences research, enabling the quantification and analysis of proteins in various biological samples. These assays are critical for understanding protein function, structure, and interactions, which are essential for developing new drugs, diagnostics, and therapies. The increasing focus on proteomics, the large-scale study of proteins, has significantly driven the demand for protein assays. In fields such as biotechnology, pharmaceuticals, and clinical diagnostics, protein assays are indispensable for quality control, drug discovery, and disease diagnosis. The growing prevalence of chronic diseases and the need for personalized medicine further underscore the importance of accurate and reliable protein assays in modern healthcare.
How Are Technological Advancements Influencing the Market?
Technological advancements have played a pivotal role in the evolution of protein assays. The development of high-throughput assays and automated systems has revolutionized the field, enabling the rapid and accurate quantification of proteins in complex biological samples. Innovations in fluorescence and luminescence-based assays have improved sensitivity and specificity, allowing researchers to detect low-abundance proteins with greater precision. The integration of microfluidics and lab-on-a-chip technologies has also enhanced the efficiency and scalability of protein assays, making them more accessible to researchers across various disciplines. Additionally, advancements in bioinformatics and data analysis tools have facilitated the interpretation of complex protein data, further driving the adoption of advanced protein assays in research and clinical settings.
What Are the Emerging Applications of Protein Assays?
Protein assays are increasingly being applied in emerging fields such as personalized medicine, biomarker discovery, and immunotherapy. In personalized medicine, protein assays are used to identify specific biomarkers that can guide the selection of targeted therapies for individual patients. The rise of immunotherapy, particularly in cancer treatment, has also driven the demand for protein assays that can assess the expression levels of immune checkpoint proteins, which are critical for determining the efficacy of these therapies. Additionally, protein assays are being used in the development of novel diagnostic tools, such as point-of-care tests, that provide rapid and accurate results at the patient’s bedside. These emerging applications are expanding the scope and utility of protein assays in both research and clinical practice.
What Are the Key Growth Drivers in the Market?
The growth in the protein assays market is driven by several factors. The increasing focus on proteomics and the need for advanced tools to study protein function and interactions are major drivers. Technological advancements, such as the development of high-throughput and automated assays, have significantly improved the efficiency and accuracy of protein quantification, driving their adoption in research and clinical settings. The growing prevalence of chronic diseases and the demand for personalized medicine have also spurred the need for reliable protein assays. Emerging applications, particularly in biomarker discovery and immunotherapy, are further expanding the market. Additionally, the integration of advanced data analysis tools and bioinformatics is enhancing the utility of protein assays, making them indispensable in modern life sciences research.
Select Competitors (Total 11 Featured) -
Abcam PLC
Bio-Rad Laboratories, Inc.
Biovision Inc.
Cell Signaling Technology, Inc.
GE Healthcare Life Sciences
Geno Technology Inc.
Lonza Group AG
Merck KgaA
Novus Biologicals LLC
PerkinElmer, Inc.
Promega Corporation
Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
An Overview of Protein Assays Market
Protein Assays - Global Key Competitors Percentage Market Share in 2024 (E)
A Prelude into Market Leading Players
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in R&D Initiatives by Public and Private Companies is anticipated to Bolster Market Demand
Encouraging initiatives in Proteomics Research is Fuelling Worldwide Protein Assay Market
Rise in Biotech and Pharmaceutical R&D Expenditure Augurs Well for Market Growth
Global Pharmaceutical Industry: Breakdown of Total R&D Spend in USD Billion for years 2018, 2019, 2020, 2021, 2022
Increase in Cancer Prevalence: An Opportunity Indicator for Protein Assays Market
Increase in Technological Advancements to Fuel Growth in Protein Assay Market
Rising Demand in Biomedical research Propels Market Growth
Increasing Use in Drug Discovery and Development Expands Addressable Market Opportunity
Technological Advancements in Assay Sensitivity Strengthen Market Position
Growing Focus on Personalized Medicine Drives Adoption of Protein Assays
Surge in Demand for High-Throughput Screening Generates New Opportunities
Development of Multiplex Protein Assays Sustains Market Growth
Expanding Applications in Diagnostic Testing Throws Spotlight on Market Potential
Surge in Demand for Quantitative Proteomics Expands Market Horizons
Growing Awareness of Early Disease Detection Drives Market Adoption
Innovations in Microplate and Automated Assay Systems Generate New Market Opportunities
Rising Demand for Cost-Effective and Scalable Assay Solutions Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Protein Assays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Absorbance-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Colorimetric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Fluorescence-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: USA Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: USA 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Canada 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 65: Canada Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Canada Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Canada 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
JAPAN
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 68: Japan Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Japan 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 74: Japan Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Japan Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Japan 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 77: Japan Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Japan Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Japan 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
CHINA
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 80: China Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: China Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: China 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: China Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: China 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 86: China Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: China Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: China 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 89: China Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: China Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: China 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
EUROPE
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 92: Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 98: Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 101: Europe Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 102: Europe Historic Review for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Europe 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 104: Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
FRANCE
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 107: France Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: France Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: France 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 110: France Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: France Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: France 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 113: France Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: France Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: France 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 116: France Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: France Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: France 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
GERMANY
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 119: Germany Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Germany Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Germany 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 122: Germany Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Germany Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Germany 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 125: Germany Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Germany Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Germany 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 128: Germany Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Germany Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Germany 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
ITALY
TABLE 131: Italy Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Italy Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Italy 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 134: Italy Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Italy Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Italy 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 137: Italy Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Italy Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Italy 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 140: Italy Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Italy Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Italy 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
UNITED KINGDOM
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 143: UK Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: UK Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: UK 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 146: UK Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: UK Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: UK 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 149: UK Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: UK Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: UK 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 152: UK Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: UK Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: UK 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Asia-Pacific 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Asia-Pacific Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Asia-Pacific 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Asia-Pacific Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Asia-Pacific 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Asia-Pacific Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Asia-Pacific 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 179: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of World Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of World 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
TABLE 182: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of World Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of World 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
TABLE 185: Rest of World Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of World Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of World 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 188: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of World Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of World 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
